Pulse Biosciences, Inc.
- PLSE
- NASDAQ
- Medical - Instruments & Supplies
- Bioelectric Medicine
- Nano-Pulse Stimulation
- Dermatology Devices
$50.84
Today +6.92%Quote Oct 20, 2026, 08:00 PM UTC
−4.63%over the last month
Max drawdown −17.4%From 1-month high −5.5%3 months +55.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Pulse Biosciences
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NASDAQ
Employees
116
Founded
2014
Market value
$3.63B
Quote Oct 20
Floor
$47.24
7.1% below price
Resistance
$50.82
Price is above this level
Price vs analyst targets
6 analysts
Lowest target
$55.00Highest target
$70.00
$55.00Highest target
$70.00
- Price $50.84
- Average target $60.20
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 18% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PLSEPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free